Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells
- PMID: 22019956
- PMCID: PMC4010209
- DOI: 10.1038/aps.2011.122
Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells
Abstract
Aim: Survivin molecular beacons can be used to detect bladder cancer cells in urine samples non-invasively. The aim of this study is to improve the specificity of detection of bladder cancer cells using survivin dual fluorescence resonance energy transfer molecular beacons (FRET MBs) that have fluorophores forming one donor-acceptor pair.
Methods: Survivin-targeting dual fluorescence resonance energy transfer molecular beacons with unique target sequences were designed, which had no overlap with the other genes in the apoptosis inhibitor protein family. Human bladder cancer cell lines 5637, 253J and T24, as well as the exfoliated cells in the urine of healthy adults and patients with bladder cancer were examined. Images of cells were taken using a laser scanning confocal fluorescence microscope. For assays using dual FRET MBs, the excitation wavelength was 488 nm, and the emission detection wavelengths were 520±20 nm and 560±20 nm, respectively.
Results: The human bladder cancer cell lines and exfoliated cells in the urine of patients with bladder cancer incubated with the survivin dual FRET MBs exhibited strong fluorescence signals. In contrast, no fluorescence was detected in the survivin-negative human dermal fibroblasts-adult (HDF-a) cells or exfoliated cells in the urine of healthy adults incubated with the survivin dual FRET MBs.
Conclusion: The results suggest that the survivin dual FRET MBs may be used as a specific and non-invasive method for early detection and follow-up of patients with bladder cancer.
Figures




Similar articles
-
Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.Urology. 2007 Jul;70(1):60-4. doi: 10.1016/j.urology.2007.03.023. Urology. 2007. PMID: 17656209
-
Dual FRET molecular beacons for mRNA detection in living cells.Nucleic Acids Res. 2004 Apr 14;32(6):e57. doi: 10.1093/nar/gnh062. Nucleic Acids Res. 2004. PMID: 15084672 Free PMC article.
-
Preliminary study of diagnostic utility of molecular beacons in bladder cancer.Urology. 2010 Aug;76(2):512.e8-13. doi: 10.1016/j.urology.2010.04.023. Epub 2010 Jun 25. Urology. 2010. PMID: 20579701
-
Survivin: role in diagnosis, prognosis, and treatment of bladder cancer.Adv Anat Pathol. 2006 May;13(3):122-6. doi: 10.1097/00125480-200605000-00003. Adv Anat Pathol. 2006. PMID: 16778475 Review.
-
Bladder cancer detection with urinary survivin, an inhibitor of apoptosis.Front Biosci. 2002 Feb 1;7:e36-41. doi: 10.2741/sharp. Front Biosci. 2002. PMID: 11815300 Review.
Cited by
-
Dual-Color Fluorescence Imaging of EpCAM and EGFR in Breast Cancer Cells with a Bull's Eye-Type Plasmonic Chip.Sensors (Basel). 2017 Dec 19;17(12):2942. doi: 10.3390/s17122942. Sensors (Basel). 2017. PMID: 29257118 Free PMC article.
-
HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies - after photodynamic diagnosis (PDD).Cent European J Urol. 2012;65(3):146-50. doi: 10.5173/ceju.2012.03.art10. Epub 2012 Sep 4. Cent European J Urol. 2012. PMID: 24578952 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. - PubMed
-
- Sasaki T, Horikawa M, Orikasa K, Sato M, Arai Y, Mitachi Y, et al. Possible relationship between the risk of Japanese bladder cancer cases and the CYP4B1 genotype. Jpn J Clin Oncol. 2008;38:634–40. - PubMed
-
- Tsui KH, Juang HH, Lee TH, Chang PL, Chen CL, Yung BY. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Acta Pharmacol Sin. 2008;29:364–70. - PubMed
-
- Van Tilborg AA, Bangma CH, Zwarthoff EC. Bladder cancer biomarkers and their role in surveillance and screening. Int J Urol. 2009;16:23–30. - PubMed
-
- Schultz IJ, Witjes JA, Swinkels DW, de Kok JB. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin. Clin Chim Acta. 2006;368:20–32. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical